H19 was also reported as a pro-oncogenic during the development of chronic inflammation-mediated HCC in the Mdr2-KO mouse model, mainly by increasing liver injury and decreasing hepatocyte polyploidy in young mice [52]. This evidence concerns the gene H19 and hepatocellular carcinoma.